Impact of the number of Neoadjuvant Chemotherapy (NAC) cycles on survival and morbidity in patients with advanced epithelial ovarian cancer FIGO III-IV
Objectives : to assess the impact of 3-4 vs 6 cycles of neoadjuvant chemotherapy (NAC) and cytoreductive outcomes on overall survival (OS) and progression free survival (PFS) in patients undergoing interval debulking surgery (IDS) or closing debulking surgery for advanced ovarian cancer. Methods : a...
Saved in:
Main Authors : | , , , , |
---|---|
Corporate Authors : | , |
Format : | Thesis |
Language : | anglais français |
Title statement : | Impact of the number of Neoadjuvant Chemotherapy (NAC) cycles on survival and morbidity in patients with advanced epithelial ovarian cancer FIGO III-IV / Marine Godfroy; sous la direction de Cécile Loaec |
Published : |
Nantes :
Université de Nantes
, 2019 |
Online Access : |
Via Nantes Université network
|
Note de thèse : | Reproduction de : Thèse d'exercice : Médecine. Gynécologie-Obstétrique : Nantes : 2019 |
Conditions d'accès : | Thèse soumise à l'embargo de l'auteur jusqu'au 01-01-2021. |
Subjects : | |
Related Items : | Is reproduction of:
Impact of the number of Neoadjuvant Chemotherapy (NAC) cycles on survival and morbidity in patients with advanced epithelial ovarian cancer FIGO III-IV |